Revolutionary Cancer Treatment: AI Discovers Personalized Drug Combinations
DeepMind's AlphaFold 3 identifies optimal drug combinations for individual cancer patients based on their genetic profile, leading to 80% higher remission rates in clinical trials.
Neuralink Begins Human Trials: First Patient Controls Computer with Thoughts
Elon Musk's brain-computer interface company successfully demonstrates a paralyzed patient playing chess and browsing the internet using only their thoughts, opening new possibilities for assistive technology.


